PRMT5 and Miyoshi myopathy: We then analysed the impact of PRMT5 silencing on the clonogenic potential of selected MM cell lines, representative of MTAP‐positive (MPP 89) and MTAP‐negative (NCI‐H2452, MMB‐1) cells.